- Home
- MYTE vs PRQR Comparison
MYTE vs PRQR Comparison
Compare MYTE & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYTE
- PRQR
- Stock Information
- Founded
- MYTE 2006
- PRQR 2012
- Country
- MYTE Germany
- PRQR Netherlands
- Employees
- MYTE N/A
- PRQR N/A
- Industry
- MYTE Catalog/Specialty Distribution
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- MYTE Consumer Discretionary
- PRQR Health Care
- Exchange
- MYTE Nasdaq
- PRQR Nasdaq
- Market Cap
- MYTE 327.4M
- PRQR 309.5M
- IPO Year
- MYTE 2021
- PRQR 2014
- Fundamental
- Price
- MYTE $7.25
- PRQR $2.68
- Analyst Decision
- MYTE Buy
- PRQR Strong Buy
- Analyst Count
- MYTE 2
- PRQR 5
- Target Price
- MYTE $4.88
- PRQR $7.60
- AVG Volume (30 Days)
- MYTE 224.6K
- PRQR 567.2K
- Earning Date
- MYTE 11-19-2024
- PRQR 11-07-2024
- Dividend Yield
- MYTE N/A
- PRQR N/A
- EPS Growth
- MYTE N/A
- PRQR N/A
- EPS
- MYTE N/A
- PRQR N/A
- Revenue
- MYTE $953,698,416.00
- PRQR $20,506,357.00
- Revenue This Year
- MYTE $10.88
- PRQR $235.11
- Revenue Next Year
- MYTE $9.72
- PRQR N/A
- P/E Ratio
- MYTE N/A
- PRQR N/A
- Revenue Growth
- MYTE 9.97
- PRQR 306.68
- 52 Week Low
- MYTE $2.41
- PRQR $1.61
- 52 Week High
- MYTE $8.24
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- MYTE 69.44
- PRQR 40.12
- Support Level
- MYTE $7.01
- PRQR $2.27
- Resistance Level
- MYTE $7.89
- PRQR $2.95
- Average True Range (ATR)
- MYTE 0.42
- PRQR 0.28
- MACD
- MYTE 0.10
- PRQR -0.10
- Stochastic Oscillator
- MYTE 88.79
- PRQR 36.66
About MYTE MYT Netherlands Parent B.V. each representing one
MYT Netherlands Parent BV is a luxury e-commerce platform. The company offers luxury fashion wear for men, women, and kids. Also, the company sells shoes, bags, and accessories. The company operates in two segments which include the online segment and Retail store segments in which the majority of its revenue is generated from the Online segment.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.